Leadership Team

Our team combines drug discovery specialists with physicists, chemists and computer scientists committed to use cutting-edge technologies to make a difference to people’s lives.

Vid Stojevic, PhD

CEO, Co-founder

Expert in Quantum Physics and Artificial Intelligence

David Wright, PhD

CTO, Co-founder

Expert in Molecular Modelling and Simulation

Denise Moody

COO

Leader in Operations, ex-Roche, Bayer and AstraZeneca

Darren Millington

CFO

Seasoned Biotech Executive, ex-Summit and Rayner

Parminder Ruprah, PhD

Head of Chemistry, Co-founder

Highly experienced “Drug Hunter”, ex-Takeda and Pfizer

Cat Stace, PhD

EVP of Business Development

Expert Computational Scientists

Our in-house expertise blends quantum physics, modelling, simulation, AI/ML and discovery/medicinal chemistry.

 

Jarryl D’Oyley, PhD

Project Manager, Co-founder

Georg Schusteritsch, PhD

Senior Quantum Scientist

Will Gerrard, PhD

Computational Drug Design

Alex Punter, PhD

Computational Drug Design

 
 

Raphael Chantreau, PhD

Computational Drug Design

Charlie Adams, PhD

KTP Associate

Tim Katte, PhD

Computational Drug Design

Anthony Nash, PhD

Computational Drug Design

 

Our Advisors

We are supported by an expert team of advisors that are working closely with us on corporate and business development, as well as, ongoing scientific development of our proprietary modelling and AI technology.

Key advisors include:

 

Alessandra Cesano, PhD

Seasoned senior executive

ESSA Pharmaceuticals

Prof. Adrian Mulholland

Head of Physical and Theoretical Chemistry

University of Bristol

Prof. Andrew Green

Chair of Condensed Matter Physics

UCL

Jarvist Moore-Frost, PhD

Royal Society Research Fellow

Imperial College London

 

Board of Directors

 

Antonio Benedetti

Executive Chairman

Andy Mulvaney

Non-Exec Director

Vid Stojevic

CEO

Mike Murphy

Board Observer

David Wright

CTO

Robert Hornby

Board Observer


Sunil Shah

Non-Exec Director

Ted Witek

Board Member

 

Our Partners

We are currently backed by a series of seed round investors, grants and academic partners.

 

AI Seed

AI and ML Fund

London, UK

 

Angel CoFund

Angel Investors

London, UK

 

o2h Ventures

Biotech & AI fund

Cambridge, UK

 

Wren Investments

Multi-family investments

London, UK

 
 

Meltwind

Biotech fund

Cambridge, UK

Syndicate Room

Angel network

Cambridge, UK

Cambridge Angels

Angel investors

Cambridge, UK